Hilda Ortiz Morales
Nurse Practitioner · Fort Lauderdale, FLNPI 1902008832
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $31,559 of the $45,277 with a category attached, or 69.7%. 7 manufacturers reported payments, led by Janssen Scientific Affairs, LLC at 49.1% of the total. Reporting peaked in 2022 at $27,745 and has fallen 99.8% since, to $57 in 2025. Among nurse practitioner clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 260 payments — averaging $174.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Scientific Affairs, LLC$22K
- Gilead$18K
- Johnson & Johnson$2K
- Janssen Products, LP$2K
- AbbVie$982
- Viiv Healthcare Company$416
- plus $14 from 1 others
What the payments were for
- Consulting fees$1,1603%
- Speaking & faculty fees$31,55970%
- Travel & lodging$6,07513%
- Food & beverage$6,25314%
- Education$2301%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Scientific Affairs, LLC | 16 | $22,229 |
| Gilead | 84 | $17,875 |
| Johnson & Johnson | 107 | $2,039 |
| Janssen Products, LP | 16 | $1,722 |
| AbbVie | 14 | $982 |
| Viiv Healthcare Company | 22 | $416 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$45,277 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 84 | $323,353 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 45 | $291,146 |
| JulucaDolutegravir/Rilpivirine | 30 | $104,070 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 12 | $40,821 |
| DescovyEmtricitabine/Tenofov Alafenam | 16 | $35,052 |
| OzempicSemaglutide | 17 | $18,476 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $894 |
| Diclofenac Sodium | 18 | $554 |
| Atorvastatin Calcium | 57 | $445 |
| Gabapentin | 27 | $420 |
| Nifedipine ErNifedipine | 27 | $348 |
| Rosuvastatin Calcium | 19 | $243 |
| Amlodipine Besylate | 69 | $219 |
| Omeprazole | 16 | $206 |
| Lisinopril | 46 | $191 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $17,875 | $358,405100 claims |
| Janssen Products, LPSymtuza | $1,722 | $291,14645 claims |
| Viiv Healthcare CompanyJuluca | $416 | $104,07030 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Fort Lauderdale
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.